These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 13823810)

  • 1. [Progressive scleroderma with considerable electromyographical changes treated with chelating agents (E.D.T.A.)].
    da FONSECA
    J Med (Oporto); 1960 Feb; 41():469-76. PubMed ID: 13823810
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the therapy of systematized scleropathy (progressive scleroderma) and systematized sarcoidosis with the chelating agent Na2EDTA].
    LANGHOF H; ZABEL H
    Dtsch Gesundheitsw; 1962 Feb; 17():188-97. PubMed ID: 14462154
    [No Abstract]   [Full Text] [Related]  

  • 3. [1st therapeutic trials of "chelating agents" (EDTA) in cases of scleroderma and of other fibrosclerotic processes of the dermal connective tissues].
    AGOSTINI A; ZANCA A
    G Ital Dermatol; 1961; 102():85-106. PubMed ID: 13859615
    [No Abstract]   [Full Text] [Related]  

  • 4. The treatment of scleroderma with the new chelating agent, edathamil.
    MULLER SA; BRUNSTING LA; WINKELMANN RK
    AMA Arch Derm; 1959 Aug; 80(2):187-94. PubMed ID: 13669744
    [No Abstract]   [Full Text] [Related]  

  • 5. Edathamil in the treatment of scleroderma and calcinosis cutis.
    WINDER PR; CURTIS AC
    Arch Dermatol; 1960 Nov; 82():732-6. PubMed ID: 13785770
    [No Abstract]   [Full Text] [Related]  

  • 6. Scleroderma. An evaluation of treatment with disodium edetate.
    NELDNER KH; WINKELMANN RK; PERRY HO
    Arch Dermatol; 1962 Sep; 86():305-9. PubMed ID: 14478876
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of diffuse progressive scleroderma.
    EVANS JA; RUBITSKY HJ; PERRY AW
    J Am Med Assoc; 1953 Mar; 151(11):891-9. PubMed ID: 13022338
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of progressive scleroderma].
    WEISENBERG G
    Z Haut Geschlechtskr; 1952 Mar; 12(5):203-10. PubMed ID: 14951474
    [No Abstract]   [Full Text] [Related]  

  • 9. A technique for intravenous therapy in patients with scleroderma and in apprehensive children.
    LUNDY JS
    AMA Arch Derm; 1959 Aug; 80(2):226-7. PubMed ID: 13669755
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic sclerosis. Fourteen cases treated with chelation (disodium EDTA) and/or pyridoxine, with comments on the possible role of altered tryptophan metabolism in pathogenesis.
    BIRK RE; RUPE CE
    Henry Ford Hosp Med Bull; 1962 Dec; 10():523-53. PubMed ID: 13968436
    [No Abstract]   [Full Text] [Related]  

  • 11. [Favorable effects of prednisolone (deltacortril) in a case of progressive diffuse scleroderma].
    WIEME RJ
    Belg Tijdschr Geneesk; 1956 May; 12(9):504-6. PubMed ID: 13328782
    [No Abstract]   [Full Text] [Related]  

  • 12. Relaxin (releasin) therapy in diffuse progressive scleroderma; a preliminary report.
    EVANS JA
    AMA Arch Derm; 1959 Feb; 79(2):150-8. PubMed ID: 13616712
    [No Abstract]   [Full Text] [Related]  

  • 13. [Case of diffuse scleroderma treated with modern active methods].
    INGERMAN IL
    Vestn Venerol Dermatol; 1952; 15(6):54. PubMed ID: 13039254
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of the chelating agent edathamil disodium in acrosclerosis, sarcoidosis and other skin conditions with comments on tryptophan metabolism in sarcoidosis.
    JOHNSON SA
    Wis Med J; 1960 Oct; 59():651-5. PubMed ID: 13790343
    [No Abstract]   [Full Text] [Related]  

  • 15. [The therapy of scleroderma with chelating agents].
    NEJEDLY O; PIPER HG
    Hautarzt; 1960 Aug; 11():378-9. PubMed ID: 13728235
    [No Abstract]   [Full Text] [Related]  

  • 16. [Progressive scleroderma].
    NAGELE E; PFISTER R
    Ergeb Inn Med Kinderheilkd; 1956; 7():244-77. PubMed ID: 13375613
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of scleroderma with the disodium salt of ethylenediaminetetraacetic acid: a contribution to the toxicology of versenate. Part 1].
    HOESLI P
    Arzneimittelforschung; 1960 Feb; 10():65-74. PubMed ID: 14402320
    [No Abstract]   [Full Text] [Related]  

  • 18. Roentgen manifestations in progressive systemic sclerosis (diffuse scleroderma).
    GONDOS B
    Am J Roentgenol Radium Ther Nucl Med; 1960 Aug; 84():235-47. PubMed ID: 13850944
    [No Abstract]   [Full Text] [Related]  

  • 19. Scleroderma (acrosclerosis). I. Treatment of three cases of the non-calcific variety by Chelation (EDTA).
    RUKAVINA JG; MENDELSON C; PRICE JM; BROWN RR; JOHNSON SA
    J Invest Dermatol; 1957 Oct; 29(4):273-88. PubMed ID: 13491891
    [No Abstract]   [Full Text] [Related]  

  • 20. Generalized progressive scleroderma.
    CORNBLEET T; SCHORR H; KAGEN MS
    Arch Derm Syphilol; 1948 Mar; 57(3 Pt. 2):484. PubMed ID: 18213776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.